VETOQUINOL Corporate brochure 2007 (year 2006)

SECTOR AND VOCATION V étoquinol bases its choice on 2 principles: of the species which Vétoquinol knows best, it has opted for species with the most potential, striking a balance between companion animals and livestock. The advantage of this reasoning is that it avoids the risks which cyclically affect the livestock sector. COMPANION ANIMALS DOGS, CATS, EXOTICS Emotions play a crucial role in this sector. Owners want treatments which are effective, quick and easy to administer for their companion animals. The animal’s well-being and the quality of its relationship with humans must be taken into account. There is considerable potential in this rapidly growing market in terms of products and geographic areas. LIVESTOCK CATTLE, PIGS In order to satisfy the demands of economics, which are of prime importance in this sector,Vétoquinol is constantly innovating and providing more effective treatments with both animal and consumer in mind. By targeting two species in particular, cattle and pigs, Vétoquinol is able to minimise any fluctuations in their respective markets whilst continuing to produce the bulk quantities it needs for investment. PRODUCT DYNAMISM Vétoquinol confirms its strategy of concentrating on its strengths: treatment of infectious diseases, management of pain and inflammation, cardiology/nephrology. The major brands have experienced strong growth: +18% in 2006. BALANCE BETWEEN SPECIES AND PRODUCT DYNAMISM Vétoquinol is constantly trying to strike a balance between livestock and companion animals by concentrating on its strengths. 20 - 21 47% Companion animals 34% Cattle 12% Pigs 7% Other TURNOVER BY SPECIES 2006 43% Infectious diseases 12% Pain and inflammation 3% Cardiology/nephrology 42% Other TURNOVER BY THERAPEUTIC CATEGORY 2006